文献速递肿瘤 PET/CT

减计数与卷积神经网络去噪的[18F]-FDG PET/CT图像对肺部病灶可检测性的观察者研究:面向肺癌筛查的可行性评估

Lung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-25

本研究回顾性分析49例患者141个肺部病灶在588个重建图像中的可检测性,模拟总计数100%、30%、5%、2%、1%的减计数数据并用卷积神经网络去噪。结果显示未去噪时肺部病灶可检测性维持至30%注射活度,去噪后维持至10%;去噪显著提高高诊断置信度评分比例。作者认为减活度[18F]-FDG PET/CT作为肺病灶检测工具的可行性得到支持。

要点

  • 未去噪时肺部病灶可检测性维持至30%注射活度,去噪后维持至10%。
  • 去噪显著增加高诊断置信度(评分3和0)的肺部病灶评分比例(p < 0.038)。
  • 作者认为结果支持减活度[18F]-FDG PET/CT作为肺病灶检测的潜在工具。

核心结论

  • 肺部病灶可检测性在未去噪时维持至30%注射活度,在去噪后维持至10%。
  • 结果支持减活度[18F]-FDG PET/CT作为肺部病灶检测的潜在工具。
  • 作者指出需进一步研究将该方法与低剂量CT在筛查场景中进行比较。

研究设计与样本

  • 回顾性分析49例患者共141个肺部病灶,涵盖588个重建图像。
  • 按总计数百分比水平模拟减计数PET数据,减计数水平为100%、30%、5%、2%、1%。
  • 全计数与减计数数据集均使用经训练以重建全计数PET的卷积神经网络算法去噪。
  • 两名阅片者对每个病灶评估3至0分的可检测性评分,比较全计数与各减计数水平(去噪与未去噪)的可检测性评分和定量测量。

主要发现

  • 二分类肺部病灶恶性评分在未去噪10%减计数时与全计数相比有显著差异(p < 0.029),在去噪5%减计数时与全计数相比有显著差异(p < 0.001)。
  • 与全计数相比,可检测性评分分布在未去噪2%减计数时差异显著(p < 0.001),在去噪5%减计数时差异显著(p < 0.001)。
  • 相同减计数水平下去噪与未去噪的可检测性评分在10%、2%、1%减计数时差异显著(p < 0.019),二分类评分无显著差异。
  • 去噪显著增加高诊断置信度(评分3和0)的肺部病灶评分比例(p < 0.038)。

局限性

  • 作者指出需进一步研究将该方法与低剂量CT在筛查场景中进行比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess feasibility of lung cancer screening, we analysed lung lesion detectability simulating low-dose and convolutional neural network (CNN) denoised [18F]-FDG PET/CT reconstructions. METHODS: Retrospectively, we analysed lung lesions on full statistics and decimated [18F]-FDG PET/CT. Reduced count PET data were emulated according to various percentage levels of total. Full and reduced statistics datasets were denoised using a CNN algorithm trained to recreate full statistics PET. Two readers assessed a detectability score from 3 to 0 for each lesion. The resulting detectability score and quantitative measurements were compared between full statistics and the different decimation levels (100%, 30%, 5%, 2%, 1%) with and without denoising. RESULTS: We analysed 141 lung lesions from 49 patients across 588 reconstructions. The dichotomised lung lesion malignancy score was significantly different from 10% decimation without denoising (p < 0.029) and from 5% decimation with denoising (p < 0.001). Compared to full statistics, detectability score distribution differed significantly from 2% decimation without denoising (p < 0.001) and from 5% decimation with denoising (p < 0.001). Detectability scores at same decimation levels with or without denoising differed significantly at 10%, 2%, and 1% decimation (p < 0.019); dichotomised scores did not differ significantly. Denoising significantly increased the proportion of lung lesion scores with a high diagnostic confidence (3 and 0) (p < 0.038). CONCLUSION: Lung lesion detectability was preserved down to 30% of injected activity without denoising and to 10% with denoising. These results support the feasibility of reduced-activity [18F]-FDG PET/CT as a potential tool for lung lesion detection. Further studies are warranted to compare this approach with low-dose CT in screening settings.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Faist D, Gnesin S, Medici S, et al. Lung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening. Eur J Nucl Med Mol Imaging. 2025. PMID: 40278856. doi:10.1007/s00259-025-07259-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。